{"id":57916,"date":"2024-02-27T18:07:23","date_gmt":"2024-02-27T18:07:23","guid":{"rendered":"https:\/\/medsname.com\/lacoma-t-eye-drops\/"},"modified":"2026-04-30T10:24:19","modified_gmt":"2026-04-30T10:24:19","slug":"lacoma-t-eye-drops","status":"publish","type":"product","link":"https:\/\/medsbase.com\/el\/lacoma-t-eye-drops\/","title":{"rendered":"Lacoma-T Eye Drops"},"content":{"rendered":"

<\/p>\n

\n

\u26a1 Quick Answer \u2014 What is Lacoma-T Eye Drops?<\/h3>\n

Lacoma-T Eye Drops combines latanoprost 0.005% (prostaglandin) with timolol 0.5% (beta-blocker) in one bottle. Once-daily evening dosing. Powerful 30\u201335% IOP reduction. Avoid in asthma, severe COPD, bradycardia, AV block.<\/p>\n<\/div>\n

\u0393\u03b9\u03b1\u03c4\u03af \u03bd\u03b1 \u03b1\u03b3\u03bf\u03c1\u03ac\u03c3\u03b5\u03c4\u03b5 \u03b1\u03c0\u03cc \u03c4\u03b7 MedsBase;<\/strong> \u03a0\u03c1\u03bf\u03ad\u03c1\u03c7\u03b5\u03c4\u03b1\u03b9 \u03b1\u03c0\u03cc \u03ad\u03bd\u03b1\u03bd \u03ba\u03b1\u03c4\u03b1\u03c3\u03ba\u03b5\u03c5\u03b1\u03c3\u03c4\u03ae \u03c0\u03b9\u03c3\u03c4\u03bf\u03c0\u03bf\u03b9\u03b7\u03bc\u03ad\u03bd\u03bf \u03b1\u03c0\u03cc \u03c4\u03bf\u03bd WHO-GMP \u00b7 \u0394\u03b9\u03b1\u03ba\u03c1\u03b9\u03c4\u03b9\u03ba\u03ae \u03c3\u03c5\u03c3\u03ba\u03b5\u03c5\u03b1\u03c3\u03af\u03b1 \u00b7 \u03a0\u03b1\u03b3\u03ba\u03cc\u03c3\u03bc\u03b9\u03b1 \u03b1\u03c0\u03bf\u03c3\u03c4\u03bf\u03bb\u03ae \u00b7 1,400+ \u03b5\u03c0\u03b1\u03bb\u03b7\u03b8\u03b5\u03c5\u03bc\u03ad\u03bd\u03b5\u03c2 \u03ba\u03c1\u03b9\u03c4\u03b9\u03ba\u03ad\u03c2 \u03c0\u03b5\u03bb\u03b1\u03c4\u03ce\u03bd<\/a><\/div>\n

\ud83d\udce6 \u039a\u03ac\u03b8\u03b5 \u03c0\u03b1\u03c1\u03b1\u03b3\u03b3\u03b5\u03bb\u03af\u03b1 \u03ba\u03b1\u03bb\u03cd\u03c0\u03c4\u03b5\u03c4\u03b1\u03b9 \u03b1\u03c0\u03cc \u03c4\u03b7\u03bd \u03a0\u03bf\u03bb\u03b9\u03c4\u03b9\u03ba\u03ae \u0395\u03b3\u03b3\u03cd\u03b7\u03c3\u03b7\u03c2 \u0395\u03c0\u03b1\u03bd\u03b1\u03c0\u03bf\u03c3\u03c4\u03bf\u03bb\u03ae\u03c2<\/strong><\/a> \u2014 \u03b5\u03ac\u03bd \u03c4\u03bf \u03b4\u03ad\u03bc\u03b1 \u03c3\u03b1\u03c2 \u03b4\u03b5\u03bd \u03c6\u03c4\u03ac\u03c3\u03b5\u03b9 \u03b5\u03bd\u03c4\u03cc\u03c2 20 \u03b5\u03c1\u03b3\u03ac\u03c3\u03b9\u03bc\u03c9\u03bd \u03b7\u03bc\u03b5\u03c1\u03ce\u03bd, \u03c4\u03bf \u03b5\u03c0\u03b1\u03bd\u03b1\u03c0\u03bf\u03c3\u03c4\u03ad\u03bb\u03bb\u03bf\u03c5\u03bc\u03b5.<\/p>\n

\u0393\u03b9\u03b1\u03c4\u03af \u03bd\u03b1 \u03c0\u03b1\u03c1\u03b1\u03b3\u03b3\u03b5\u03af\u03bb\u03b5\u03c4\u03b5 \u03b1\u03c0\u03cc \u03c4\u03b7 MedsBase<\/h3>\n

Lacoma-T Eye Drops is sourced from a WHO-GMP certified manufacturer and shipped worldwide in plain, discreet packaging. Every order is covered by our \u03a0\u03bf\u03bb\u03b9\u03c4\u03b9\u03ba\u03ae \u0395\u03b3\u03b3\u03cd\u03b7\u03c3\u03b7\u03c2 \u0395\u03c0\u03b1\u03bd\u03b1\u03c0\u03bf\u03c3\u03c4\u03bf\u03bb\u03ae\u03c2<\/a> \u2014 \u03b5\u03ac\u03bd \u03b4\u03b5\u03bd \u03ad\u03c7\u03b5\u03b9 \u03c6\u03c4\u03ac\u03c3\u03b5\u03b9 \u03bc\u03b5\u03c4\u03ac \u03b1\u03c0\u03cc 20 \u03b5\u03c1\u03b3\u03ac\u03c3\u03b9\u03bc\u03b5\u03c2 \u03b7\u03bc\u03ad\u03c1\u03b5\u03c2, \u03c4\u03bf \u03be\u03b1\u03bd\u03b1\u03c3\u03c4\u03ad\u03bb\u03bd\u03bf\u03c5\u03bc\u03b5 \u03c7\u03c9\u03c1\u03af\u03c2 \u03b5\u03c0\u03b9\u03c0\u03bb\u03ad\u03bf\u03bd \u03ba\u03cc\u03c3\u03c4\u03bf\u03c2. \u03a5\u03c0\u03bf\u03c3\u03c4\u03b7\u03c1\u03af\u03b6\u03b5\u03c4\u03b1\u03b9 \u03b1\u03c0\u03cc \u03c0\u03ac\u03bd\u03c9 \u03b1\u03c0\u03cc 1,400 \u03b5\u03c0\u03b1\u03bb\u03b7\u03b8\u03b5\u03c5\u03bc\u03ad\u03bd\u03b5\u03c2 \u03ba\u03c1\u03b9\u03c4\u03b9\u03ba\u03ad\u03c2 \u03c0\u03b5\u03bb\u03b1\u03c4\u03ce\u03bd.<\/p>\n

What is Lacoma-T Eye Drops?<\/h2>\n

Lacoma-T Eye Drops is a fixed-dose combination eye drop manufactured by Sun Pharma, containing latanoprost 0.005% and timolol maleate 0.5% in a 2.5 mL bottle. The two ingredients target both sides of the IOP equation \u2014 outflow (latanoprost) and production (timolol) \u2014 for once-daily 30\u201335% IOP reduction.<\/p>\n

\u03a0\u03ce\u03c2 \u039b\u03b5\u03b9\u03c4\u03bf\u03c5\u03c1\u03b3\u03b5\u03af<\/h2>\n

Latanoprost increases uveoscleral outflow via FP-receptor activation; timolol reduces aqueous production through ciliary epithelium beta-blockade. The mechanisms are complementary, making the combination roughly equivalent to taking the two drugs separately at the right intervals.<\/p>\n

\u03a7\u03bf\u03c1\u03ae\u03b3\u03b7\u03c3\u03b7<\/h2>\n

One drop in affected eye(s) once daily, in the evening. Wait 5 minutes between other eye drops. Practise punctal occlusion for 1\u20132 minutes to reduce systemic timolol absorption. Remove contact lenses; reinsert after 15 minutes.<\/p>\n

\u039a\u03b1\u03c1\u03b4\u03b9\u03b1\u03ba\u03ad\u03c2 & \u03b1\u03bd\u03b1\u03c0\u03bd\u03b5\u03c5\u03c3\u03c4\u03b9\u03ba\u03ad\u03c2 \u03b1\u03bd\u03c4\u03b5\u03bd\u03b4\u03b5\u03af\u03be\u03b5\u03b9\u03c2.<\/strong> The timolol component makes $brand contraindicated in asthma, severe COPD, sinus bradycardia, second\/third-degree AV block, and decompensated heart failure. Even ophthalmic timolol can trigger bronchospasm and bradycardia.<\/div>\n

\u03a0\u03b1\u03c1\u03b5\u03bd\u03ad\u03c1\u03b3\u03b5\u03b9\u03b5\u03c2<\/h2>\n

\u039c\u03ac\u03c4\u03b9:<\/strong> conjunctival hyperaemia (less than bimatoprost+timolol combos), iris pigmentation in light-coloured eyes (permanent), eyelash thickening, periorbital fat atrophy, mild stinging.<\/p>\n

\u03a3\u03c5\u03c3\u03c4\u03b7\u03bc\u03b9\u03ba\u03ac:<\/strong> bradycardia, fatigue, depression, bronchospasm in reactive airways, masking of hypoglycaemia signs.<\/p>\n

\u03a0\u03c1\u03bf\u03b5\u03b9\u03b4\u03bf\u03c0\u03bf\u03b9\u03ae\u03c3\u03b5\u03b9\u03c2<\/h2>\n